Ipamorelin vs GHRP-2
Both Ipamorelin and GHRP-2 are used for growth-hormone and anti-aging. Here's how their evidence, dosing, and regulatory status actually compare.
Ipamorelin
Evidence BIpamorelin Acetate
A selective growth hormone secretagogue that triggers GH release from the pituitary without significantly raising cortisol or prolactin. The safest GH peptide with the fewest side effects.
View full Ipamorelin profile →GHRP-2
Evidence BGrowth Hormone Releasing Peptide 2
A potent synthetic ghrelin-mimetic GH secretagogue. Drives strong GH spikes but raises cortisol and prolactin more than newer alternatives like Ipamorelin.
View full GHRP-2 profile →Side-by-Side
| Attribute | Ipamorelin | GHRP-2 |
|---|---|---|
| Evidence Grade | B | B |
| FDA Status | Not FDA-approved — Category 1 (compounding allowed) | Not FDA-approved — research compound; previously studied as growth hormone deficiency diagnostic |
| Typical Dose | 100–300 mcg before bed (subcutaneous) | 100–300 mcg, 1–3 times daily (subcutaneous) |
| Clinics Indexed | 195 | 86 |
| Categories | growth-hormone, anti-aging | growth-hormone, anti-aging |
Key reported benefits — Ipamorelin
- ✓Clean GH release
- ✓Improved sleep quality
- ✓Fat reduction
- ✓Joint health
Key reported benefits — GHRP-2
- ✓Strong GH release
- ✓Appetite stimulation
- ✓Muscle recovery
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.